(S)-4-Hydroxy-4-vinyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

Catalog No. :
ACPVUD188
CAS No. :
119403-33-7
Molecular Formula :
C20H14N2O4
Molecular Weight :
346.34

IUPAC Name:(S)-4-hydroxy-4-vinyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

(S)-4-Hydroxy-4-vinyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-4-Hydroxy-4-vinyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
IUPAC Name(S)-4-hydroxy-4-vinyl-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
Molecular FormulaC20H14N2O4
Molecular Weight346.34
SMILESC=C[C@@]1(O)C(=O)OCC2=C1C=C1C3=NC4=CC=CC=C4C=C3CN1C2=O
InChI KeyBSKJBXMBXQAZIZ-FQEVSTJZSA-N
SynonymCamptothecin Impurity 15;Camptothecin Impurity 10;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethenyl-4-hydroxy-, (4S)-;Campathecin Impurity 4;(20S)-18,19-Dehydrocamptothecin
CAS No.119403-33-7

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPVUD188 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPVUD188 route product structure diagram
    ACPVUD188119403-33-7
Inquiry

2. ACPVUD188 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPVUD188 route product structure diagram
    ACPVUD188119403-33-7
Inquiry

Comments (0)